Literature DB >> 12392448

Comparison of nitration and oxidation of tyrosine in advanced human carotid plaque proteins.

Lincoln W Morton1, Ian B Puddey, Kevin D Croft.   

Abstract

The importance of reactive nitrogen species in atherosclerosis remains poorly understood, despite the semi-quantitative evidence for the presence of 3-nitrotyrosine provided by immunohistochemical staining studies. At this time, there appear to be no data describing the prevalence of nitration relative to oxidation in atherosclerotic plaque proteins. The present study used 3-nitrotyrosine and dityrosine as markers of nitration and oxidation respectively to examine the relative abundance of each process. Substantial methodological improvements were required to overcome problems associated with sensitivity and artefactual production of 3-nitrotyrosine when quantified by GLC-MS. It was shown that careful selection of hydrolysis vessel, sample reduction and the use of the oxazolinone derivative provided sample stability and exquisite sensitivity. Using these methods, it was observed that the frequency of nitration was 92+/-15 micro mol/mol of tyrosine (0.01%). Dityrosine was present at 1.5+/-0.14 mmol/mol of tyrosine (0.30%) using HPLC/fluorescence; thus nitration accounted for approx. 3% of the tyrosine modifications measured. Given that other modifications of tyrosine are known to occur in carotid plaque proteins, the contribution of nitration to the total pool of modified tyrosine is very small. However, the possibility of metabolic processes or chemical agents modifying 3-nitrotyrosine to secondary oxidation products remains an alternative explanation for the low levels demonstrated in this study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12392448      PMCID: PMC1223132          DOI: 10.1042/BJ20020964

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  A novel method for the gas chromatographic determination of phenylalanine in serum.

Authors:  O Grahl-Nielsen; B Movik
Journal:  Biochem Med       Date:  1975-02

2.  Inflammation and NO(X)-induced nitration: assay for 3-nitrotyrosine by HPLC with electrochemical detection.

Authors:  M K Shigenaga; H H Lee; B C Blount; S Christen; E T Shigeno; H Yip; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

3.  Do human atherosclerotic lesions contain nitrotyrosine?

Authors:  P Evans; H Kaur; M J Mitchinson; B Halliwell
Journal:  Biochem Biophys Res Commun       Date:  1996-09-13       Impact factor: 3.575

4.  Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis.

Authors:  Joanne M Upston; Xianwa Niu; Andrew J Brown; Ryuichi Mashima; Hongjie Wang; Revathy Senthilmohan; Anthony J Kettle; Roger T Dean; Roland Stocker
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 5.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

Authors:  H C Stary; A B Chandler; S Glagov; J R Guyton; W Insull; M E Rosenfeld; S A Schaffer; C J Schwartz; W D Wagner; R W Wissler
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

Review 6.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

Authors:  H C Stary; A B Chandler; R E Dinsmore; V Fuster; S Glagov; W Insull; M E Rosenfeld; C J Schwartz; W D Wagner; R W Wissler
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

7.  Conversion of inhaled nitric oxide to nitrate in man.

Authors:  U N Westfelt; G Benthin; S Lundin; O Stenqvist; A Wennmalm
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors.

Authors:  L Jungersten; A Edlund; A S Petersson; A Wennmalm
Journal:  Clin Physiol       Date:  1996-07

9.  Nitrite and nitrate determinations in plasma: a critical evaluation.

Authors:  H Moshage; B Kok; J R Huizenga; P L Jansen
Journal:  Clin Chem       Date:  1995-06       Impact factor: 8.327

10.  Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients.

Authors:  H Kaur; B Halliwell
Journal:  FEBS Lett       Date:  1994-08-15       Impact factor: 4.124

View more
  2 in total

Review 1.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Oxidative and nitrosative modifications of tropoelastin prevent elastic fiber assembly in vitro.

Authors:  Kamal Akhtar; Thomas J Broekelmann; Ming Miao; Fred W Keeley; Barry C Starcher; Richard A Pierce; Robert P Mecham; Tracy L Adair-Kirk
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.